These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18438813)

  • 21. Anakinra: new therapeutic approach in children with Familial Mediterranean Fever resistant to colchicine.
    Roldan R; Ruiz AM; Miranda MD; Collantes E
    Joint Bone Spine; 2008 Jul; 75(4):504-5. PubMed ID: 18541452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience.
    Zeft A; Hollister R; LaFleur B; Sampath P; Soep J; McNally B; Kunkel G; Schlesinger M; Bohnsack J
    J Clin Rheumatol; 2009 Jun; 15(4):161-4. PubMed ID: 19363453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever.
    Kucuksahin O; Yildizgoren MT; Ilgen U; Ates A; Kinikli G; Turgay M; Erten S
    Mod Rheumatol; 2017 Mar; 27(2):350-355. PubMed ID: 27328763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anakinra for the treatment of familial Mediterranean fever-associated spondyloarthritis.
    Varan O; Kucuk H; Tufan A
    Scand J Rheumatol; 2016; 45(3):252-3. PubMed ID: 26948937
    [No Abstract]   [Full Text] [Related]  

  • 25. On demand use of anakinra for attacks of familial Mediterranean fever (FMF).
    Babaoglu H; Varan O; Kucuk H; Atas N; Satis H; Salman R; Ozturk MA; Haznedaroglu S; Goker B; Tufan A
    Clin Rheumatol; 2019 Feb; 38(2):577-581. PubMed ID: 30062447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.
    Lequerré T; Quartier P; Rosellini D; Alaoui F; De Bandt M; Mejjad O; Kone-Paut I; Michel M; Dernis E; Khellaf M; Limal N; Job-Deslandre C; Fautrel B; Le Loët X; Sibilia J; ;
    Ann Rheum Dis; 2008 Mar; 67(3):302-8. PubMed ID: 17947302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protracted febrile myalgia as a challenging manifestation of familial Mediterranean fever: case-based review.
    Yıldırım DG; Bakkaloglu SA; Buyan N
    Rheumatol Int; 2019 Jan; 39(1):147-152. PubMed ID: 30293156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anakinra in two adolescent female patients suffering from colchicine-resistant familial Mediterranean fever: effective but risky.
    Gattringer R; Lagler H; Gattringer KB; Knapp S; Burgmann H; Winkler S; Graninger W; Thalhammer F
    Eur J Clin Invest; 2007 Nov; 37(11):912-4. PubMed ID: 17973784
    [No Abstract]   [Full Text] [Related]  

  • 29. Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients.
    Drewe E; McDermott EM; Powell PT; Isaacs JD; Powell RJ
    Rheumatology (Oxford); 2003 Feb; 42(2):235-9. PubMed ID: 12595616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of interleukin-6 in a patient with tumor necrosis factor receptor-associated periodic syndrome: assessment of outcomes following treatment with the anti-interleukin-6 receptor monoclonal antibody tocilizumab.
    Vaitla PM; Radford PM; Tighe PJ; Powell RJ; McDermott EM; Todd I; Drewe E
    Arthritis Rheum; 2011 Apr; 63(4):1151-5. PubMed ID: 21225679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anakinra in a case of fever familial Mediterranean].
    Ferris Villanueva E; García Coronel M; Guerrero Bautista R
    Farm Hosp; 2014 Sep; 38(5):446-8. PubMed ID: 25344140
    [No Abstract]   [Full Text] [Related]  

  • 32. Positive clinical and biochemical responses to anakinra in a 3-yr-old patient with cryopyrin-associated periodic syndrome (CAPS).
    Ramos E; Aróstegui JI; Campuzano S; Rius J; Bousoño C; Yagüe J
    Rheumatology (Oxford); 2005 Aug; 44(8):1072-3. PubMed ID: 15840596
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome.
    van der Hilst JCH; Bodar EJ; Barron KS; Frenkel J; Drenth JPH; van der Meer JWM; Simon A;
    Medicine (Baltimore); 2008 Nov; 87(6):301-310. PubMed ID: 19011501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic Amyloidosis in a Patient With Familial Mediterranean Fever and Hodgkin Lymphoma: A Case Report.
    Demir F; Bahadir A; Mungan S; Çobanoğlu Ü; Kalyoncu M
    J Pediatr Hematol Oncol; 2020 Apr; 42(3):234-237. PubMed ID: 31094904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience.
    Kurt T; Aydın F; Nilüfer Tekgöz P; Sezer M; Uncu N; Çelikel Acar B
    Int J Rheum Dis; 2020 Jul; 23(7):977-981. PubMed ID: 32558310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder.
    Portincasa P; Scaccianoce G; Palasciano G
    Eur J Clin Invest; 2013 Dec; 43(12):1314-27. PubMed ID: 24117178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On-demand treatment with anakinra: a treatment option for selected TRAPS patients.
    Grimwood C; Despert V; Jeru I; Hentgen V
    Rheumatology (Oxford); 2015 Sep; 54(9):1749-51. PubMed ID: 26078218
    [No Abstract]   [Full Text] [Related]  

  • 38. Development and effect of antibodies to anakinra during treatment of severe CAPS: sub-analysis of a long-term safety and efficacy study.
    Wikén M; Hallén B; Kullenberg T; Koskinen LO
    Clin Rheumatol; 2018 Dec; 37(12):3381-3386. PubMed ID: 29982913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of interleukin-1 antagonists on the quality of life in familial Mediterranean fever patients.
    Varan O; Kucuk H; Babaoglu H; Atas N; Salman RB; Satis H; Ozturk MA; Haznedaroglu S; Goker B; Tufan A
    Clin Rheumatol; 2019 Apr; 38(4):1125-1130. PubMed ID: 30535829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes.
    Sibley CH; Plass N; Snow J; Wiggs EA; Brewer CC; King KA; Zalewski C; Kim HJ; Bishop R; Hill S; Paul SM; Kicker P; Phillips Z; Dolan JG; Widemann B; Jayaprakash N; Pucino F; Stone DL; Chapelle D; Snyder C; Butman JA; Wesley R; Goldbach-Mansky R
    Arthritis Rheum; 2012 Jul; 64(7):2375-86. PubMed ID: 22294344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.